Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism. - Wikidata - wikimedia - TriplyDB

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.

http://www.wikidata.org/entity/Q46656563

about

Association between plasma homocysteine status and hypothyroidism: a meta-analysis Dyslipidemia and serum mineral profiles in patients with thyroid disorders Serum levels of lipids, calcium and magnesium in women with hypothyroidism and cardiovascular diseases.Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver.Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism.Cholesterol Synthesis Increased in the MMI-Induced Subclinical Hypothyroidism Mice Model.Biochemical and histopathological studies of the PTU-induced hypothyroid rat kidney with reference to the ameliorating role of folic acid.Association of metabolic risks with subclinical hypothyroidism: A cross-sectional analysis.

P2860

Q34770181-361D295B-78FF-4F58-9502-032AEEB2D2B3 Q35183673-33BAF4A1-D4EC-446E-91E7-79A4958EEDF1 Q35199320-910F2757-1DCA-4212-84AA-785C7F39129C Q35536395-8B967DCC-E2A6-4F08-AFEF-689C01FCA9DB Q36454909-21461E5C-8FC9-402E-8E96-5B559851BE07 Q37721100-D8C89F5F-5233-4B09-8864-F3D85582DFE9 Q45900132-3C6C394A-4EAA-4492-88C3-04F210E18145 Q55204269-032F8EF5-5353-4CF1-BB37-FC7927A79161

P2860

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.

http://www.wikidata.org/entity/Q46656563

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@en

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@nl

type

label

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@en

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@nl

prefLabel

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@en

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@nl

P1433

Q46656563-D416DEC3-5A80-45B1-BE72-2A5546EFB1D8

P1476

Q46656563-95E07D0F-4037-4B4A-8B79-8D16AB3F71EF

P2093

Q46656563-00CEB1CC-7080-4182-8ED9-9594A72A4F91

Q46656563-1D39E04E-1F34-4E3D-9DA3-52FCB42404E4

Q46656563-2411FC05-2E2F-4A72-B4B8-52B6CB6F59BD

Q46656563-4775B49C-22C8-47A4-9554-C2FE5AA6263E

Q46656563-5317E120-7375-4EE7-B867-3A20420302B1

Q46656563-7C8B718A-5B41-469A-9A26-3060AA8DDA58

Q46656563-8CD1E4DA-E85D-4A75-9224-3D4D343C74C3

Q46656563-E0BF9E95-BFC2-4A18-A98D-B7F35C044985

P2860

Q46656563-10427B25-852C-4239-94A0-4651B8EDEF7F

Q46656563-10FCFAD7-4BC6-4267-B263-830E20910B79

Q46656563-1293CE15-81BE-46C8-B000-97987AFADADB

Q46656563-2BF29DB1-F83A-4925-9EE3-FF67CD7ED70F

Q46656563-303C01DC-4D83-42C8-9D16-77B57935186A

Q46656563-34FDF0AC-3DF4-4A4D-9F4B-B331546E520A

Q46656563-3A8E2A8E-F1C9-4785-AFB6-99268EBE4B3D

Q46656563-3CF99BD2-F818-47D2-87DD-1A0C0746B585

Q46656563-3F371491-937C-4EB9-8B41-72B0323E0F42

Q46656563-459A2D99-5072-4EFB-86A9-E04BE5297E87

P304

Q46656563-B69FD51A-21E7-49B3-854F-F908FEF3A5DB

P31

Q46656563-BD62CA26-9F62-4F69-AE55-0897F163FDF0

P356

Q46656563-76D6DDDB-DFA9-467E-A7D2-F9863D703CB9

P433

Q46656563-E53AEE7E-8FFA-4F00-8693-CE4F69364BA1

P478

Q46656563-78EACF08-2823-4E8D-9A03-B972076EC952

P577

Q46656563-80D25AD7-2220-4D0E-83B1-E64BE6C89A5C

P698

Q46656563-DFA6E585-010A-42F6-9935-D1259AE5ACF5

P921

Q46656563-B6FA985D-006F-439C-A2EC-209C7E71FDC6

P932

Q46656563-6FF7EE18-6FEA-4056-9B0D-C72C5CD659D3

P356

0256-4947.2008.96

P1433

Annals of Saudi Medicine

P1476

Plasma homocysteine concentrat ...... in subclinical hypothyroidism.

@en

P2093

Ali Guctekin

http://www.w3.org/2001/XMLSchema#string

Fatma Ucar

http://www.w3.org/2001/XMLSchema#string

Gonul Erden

http://www.w3.org/2001/XMLSchema#string

Ozlem Ozturk

http://www.w3.org/2001/XMLSchema#string

Serpil Turhan

http://www.w3.org/2001/XMLSchema#string

Sevilay Sezer

http://www.w3.org/2001/XMLSchema#string

Sezin Bingol

http://www.w3.org/2001/XMLSchema#string

Zeynep Ginis

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Subclinical thyroid disease: scientific review and guidelines for diagnosis and management

Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force.

Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey.

Homocysteine and vascular disease.

The Colorado thyroid disease prevalence study.

Cardiovascular and atherogenic aspects of subclinical hypothyroidism.

Folate and homocysteine.

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal disease.

P304

96-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5144/0256-4947.2008.96

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18398274

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

6074520

http://www.w3.org/2001/XMLSchema#string